Furthermore, due to the lack of the conventional hormonal or anti-HER2 therapeutic targets, the standardized treatment strategies have not been formulated and the chemotherapy is the only modality of systemic therapy for these cancers. The gene discussed is ERBB2; the disease is cancer.